Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism

Blood

Volumn 83, Issue 6, 1994, Pages 1575-1585

  Sirard, Christian ^b   Laneuville, Pierre ^b   Dick, John E ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; PROTEIN TYROSINE KINASE;

ARTICLE; CELL PROLIFERATION; ENZYME ACTIVITY; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0028274049     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v83.6.1575.bloodjournal8361575     Document Type: Article

References (74)

1. Sawyers CL, Denny CT, Witte ON: Leukemia and the disruption of normal hematopoiesis. Cell 64:337, 1991
2. Rowley J: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature 243:290, 1973
3. Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcript of abl and bcr genes in chonic myelogenous leukemia. Nature 315:550, 1985
4. Konopka JB, Watanabe SM, Witte ON: An alteration of the c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035, 1984
5. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited area, bcr, on chromosome 22. Cell 36:93, 1984
6. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR, Grosveld G: Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia. Nature 306:239, 1983
7. Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
8. Elefanty AG, Hariharan IK, Cory S: bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J 9:1069, 1990
9. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N: Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and bcr/abl. Proc Natl Acad Sci USA 87:6649, 1990 [erratum 87:9072, 1990]
10. Elefanty AG, Cory S: Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Mol Cell Biol 12:1755, 1992
11. Strife A, Lambek C, Wisniewski D, Wachter M, Gulati SC, Clarkson BD: Discordant maturation as the primary biological defect in chronic myelogenous leukemia. Cancer Res 48:1035, 1988
12. Eaves AC, Eaves CJ: Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML). Exp Hematol 7:65, 1979 (suppl 5)
13. Martin H, Hibbin JA, Dowding C, Matutes E, Tindle R, Goldman JM: Purification of hematopoietic progenitor cells from patients with chronic granulocytic leukemia using Percoll density gradients and elutriation. Br J Haematol 63:197, 1986
14. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ: Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 83:5306, 1986
15. Lepine J, Messner HA: Pluripotent hematopoietic progenitors (CFU-GEMM) in chronic myelogenous leukemia. Int J Cell Cloning 1:230, 1983
16. Udomsakdi C, Eaves CJ, Lansdorp PM, Eaves AC: Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myelogenous leukemia (CML). Blood 80:2522, 1992
17. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF: Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukemia. Nature 328:342, 1987
18. Eaves CJ, Eaves AC: Cell culture studies in CML. Baillieres Clin Haematol 1:931, 1987
19. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM: Heparan sulphate bound growth factors: A mechanism for stromal cell mediated haemopoiesis. Nature 332:376, 1988
20. Eaves CJ, Cashman JD, Wolpe SD, Eaves AC: Primitive myeloid chronic leukemia (CML) cells are unresponsive to MIP-1α, an inhibitor of primitive normal hematopoietic cells. Blood 80:155a, 1992 (abstr, suppl 1)
21. Sporn MB, Roberts AB: Autocrine growth factors and cancer. Nature 313:745, 1985
22. Metz T, Graf T, Leutz A: Activation of cMGF expression is a critical step in avian myeloid leukemogenesis. EMBO J 10:837, 1991
23. Young DC, Griffin JD: Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 68:1178, 1986
24. Rambaldi A, Wakamiya N, Vellenga E, Horiguchi J, Warren MK, Dufe D, Griffin JD: Expression of the macrophage colony-stimulating factor and c-fms genes in human acute myeloblastic leukemia cells. J Clin Invest 81:1030, 1988
25. Cheng GYM, Kelleher CA, Miyauchi J, Wang C, Wong G, Clark SC, McCulloch EA, Minden MD: Structure and expression of genes of GM-CSF in blast cells from patients with acute myeloblastic leukemia. Blood 71:204, 1988
26. Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann RH, Herrmann F: Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest 84:451, 1989
27. Meeker TC, Hardy D, Willman C, Hogan T, Abrams J: Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood 76:285, 1990
28. Klein H, Becher R, Lubbert M, Oster W, Schleiermacher E, Brach MA, Souza L, Lindemann A, Mertelsmann RH, Herrmann F: Synthesis of granulocyte colony-stimulating factor and its requirement for terminal division in chronic myelogenous leukemia. J Exp Med 171:1785, 1990
29. Robinson WA, Pike BL: Leukopoietic activity in human urine. N Engl J Med 282:1291, 1970
30. Janowska-Wieczorek A, Belch AR, Jacobs A, Bowen D, Padua R-A, Paietta E, Stanley ER: Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. Blood 77:1796, 1991
31. Hariharan IK, Adams JM, Cory S: bcr-abl oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res 3:387, 1988
32. bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene 6:275, 1991
33. Daley GQ, Baltimore D: Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210 bcr/abl protein. Proc Natl Acad Sci USA 85: 9312, 1988
34. Rees-Jones RW, Goldfarb M, Goff SP: Abelson murine leukemia virus induces platelet-derived growth factor-independent fibroblast growth: Correlation with kinase activity and dissociation from full morphologic transformation. Mol Cell Biol 9:278, 1989
35. Pierce JH, Di Fiore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN: Neoplastic transformation of mast cells by Abelson-MuLV: Abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41:685, 1985
36. Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE: B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50:809, 1987
37. Waneck GL, Keyes L, Rosenberg N: Abelson virus drives the differentiation of Harvey virus-infected erythroid cells. Cell 44:337, 1986
38. Mathey-Prevot B, Nabel G, Palacios R, Baltimore D: Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol Cell Biol 6:4133, 1985
39. Overell RW, Clark L, Lynch D, Jerzy R, Schmierer A, Weisser KE, Namen AE, Goodwin RB: Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine. Mol Cell Biol 11:1590, 1991
40. Cook WD, de St Groth BF, Miller JF, MacDonald HR, Gabathuler R: Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line. Mol Cell Biol 7:2631, 1987
41. Rovera G, Valtieri M, Mavilio F, Reddy P: Effect of abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene 1:29, 1987
42. Cook WD, Metcalf D, Nicola NA, Burgess AW, Walker F: Malignant transformation of a growth factor-dependent myeloid cell line by abelson virus without evidence of an autocrine mechanism. Cell 41:677, 1985
43. Oliff A, Agranovsky O, McKinney MD, Murty VVVS, Bauchwitz R: Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus. Proc Natl Acad Sci USA 82:3306, 1985
44. Chung SW, Wong PMC, Shen-Ong G, Ruscetti S, Ishizaka T, Eaves CJ: Production of granulocyte-macrophage colony-stimulating factor by abelson virus-induced tumorigenic mast cell lines. Blood 68:1074, 1986
45. Humphries RK, Abraham S, Krystal G, Lansdorp P, Lemoine F, Eaves CJ: Activation of multiple hemopoietic growth factor genes in abelson virus-transformed myeloid cells. Exp Hematol 16:774, 1988
46. Twardzick DR, Todaro GJ, Marquardt H, Reynolds JFH, Stephenson JR: Transformation induced by Abelson murine leukemia virus involves production of a polypeptide growth factor. Science 216:894, 1982
47. Adkins B, Leutz A, Graf T: Autocrine growth induced by src-related oncogenes in transformed chicken myeloid cells. Cell 39: 439, 1984
48. bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 237:532, 1987
49. Laneuville P, Chang W, Kamel-Reid S, Fauser AA, Dick JE: High-efficiency gene transfer and expression in normal human hematopoietic cells with retrovirus vectors. Blood 71:811, 1988
50. Brady G, Williams RL, Nordstrom K, Vennstrom B, Iscove NN: Selectable temperature-sensitive v-src Moloney retrovirus. Oncogene 3:687, 1988
51. Avanzi GC, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, Coda R, Cattoretti G, Pegoraro L: Selective growth response to IL-3 of a human leakemic cell line with megakaryoblastic features. Br J Haematol 69:359, 1988
52. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503, 1975
53. Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad Sci USA 81:1991, 1984
54. Konopka JB, Davis RL, Watanabe SM, Ponticelli AS, Schiff-Maker L, Rosenberg N, Witte ON: Only site-directed antibodies reactive with the highly conserved src-homology region of the v-abl protein neutralize kinase activity. J Virol 51:223, 1984
55. Laemmli UK: Cleavage of the structural proteins during the assembly of the head bacteriophage T4. Nature 277:680, 1970
56. Mosmann T: A rapid and quantitative colorimetric assay for cellular proliferation: Application to lymphokine assays, mitogen stimulations and complement-mediated cytotoxicity. J Immunol Methods 65:55, 1983
57. Scudiero DA, Shoemaker RH, Paul KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827, 1988
58. Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang Y-C, Pegoraro L, Clark SC: M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 145:458, 1990
59. Miller AD: Progress towards gene therapy. Blood 76:271, 1990
60. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321, 1975
61. Browder TM, Abrams JS, Wong PMC, Nienhuis AW: Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer. Mol Cell Biol 9:204, 1989
62. Laker C, Stocking C, Bergholz U, Hess N, De Lamarter JF, Ostertag W: Autocrine stimulation after transfer of the granulocyte/ macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc Natl Acad Sci USA 84:8458, 1987
63. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83, 1988
64. Duprez V, Lenoir G, Dautry-Varsat A: Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2. Proc Natl Acad Sci USA 82:6932, 1985
65. Arima N, Daitoku Y, Ohgaki S, Fukumori J, Tanaka H, Yamamoto Y, Fujimoto K, Onoue K: Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T-cell leukemia. Blood 68:779, 1986
66. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823, 1985
67. Fernandez-Botran R, Sanders VM, Oliver KG, Chen YW, Krammer PH, Uhr JW, Vitetta ES: Interleukin-4 mediates autocrine growth of helper T cells after antigenic stimulation. Proc Natl Acad Sci USA 83:9689, 1986
68. Rettenmier CW, Roussel MF, Ashmun RA, Ralph P, Price K, Sherr CJ: Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol Cell Biol 7:2378, 1987
69. Keating MT, Williams LT: Autocrine stimulation of intra-cellular PDGF receptors in v-sis-transformed cells. Science 239: 914, 1987
70. Huang SS, Huang JS: Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. J Biol Chem 263:12608, 1988
71. Lang RA, Metcalf D, Gough NM, Dunn AR, Gonda TJ: Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity. Cell 43:531, 1985
72. Bejcek BE, Li DY, Deuel TF: Transformation by v-sis occurs by an internal autoactivation mechanism. Science 245:1496, 1989
73. Dunbar CE, Browder TM, Abrams JS, Nienhuis AW: COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. Science 245:1493, 1989
74. Elefanty AG, Cory S: bcr-abl-induced cell lines can switch from mast cell to erythroid or myeloid differentiation in vitro. Blood 79:1271, 1992